AstraZeneca PLC (AZN) Q2 2008 Earnings Results

AstraZeneca Beats on EPS, Stock Up 3.78%

AstraZeneca's earnings report showed a positive surprise in EPS, which likely contributed to the stock's increase of 3.78%. The lack of revenue data and guidance means investors will need to wait for further information to assess the company's future performance. Overall, the strong EPS performance indicates some level of operational strength.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.25	N/A	+14.16%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

AstraZeneca Beats on EPS, Stock Up 3.78%

Key numbers

Management commentary

AstraZeneca PLC

More earnings this week

AstraZeneca Beats on EPS, Stock Up 3.78%

Key numbers

Management commentary